Inventor · disambiguated record
David R. Tabatadze
Also filed as: TABATADZE DAVID · TABATADZE DAVID R
9 granted patents·13 pending applications·17 citations·filing 2002–2024
81Inventor score
Files withZATA PHARMACEUTICALS INC7PALOMAR MEDICAL TECH INC5NEW YORK BLOOD CENTER INC3TABATADZE DAVID R2BOGDANOV ALEXEI1
Top patents by PatentIndex Score
22 records- 0185US8314226B2Oligonucleotide complex compositions and methods of use as gene alteration toolsTABATADZE DAVID R·Filed 2005·Granted Nov 20, 2012·12 cites·1 claims
- 0278US2025127168A1Method for pathogens, microorganisms, and parasites inactivationNEW YORK BLOOD CENTER INC·Filed 2024·Application pending·0 cites
- 0377US2025049031A1Method for pathogens, microorganisms, and parasites inactivationNEW YORK BLOOD CENTER INC·Filed 2024·Application pending·0 cites
- 0474US8841271B2Oligonucleotide complex compositions and methods of use as gene alteration toolsTABATADZE DAVID R·Filed 2012·Granted Sep 23, 2014·2 cites·22 claims
- 0567US10723755B2Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compoundsZATA PHARMACEUTICALS INC·Filed 2015·Granted Jul 28, 2020·1 cites·11 claims
- 0667US10173976B2Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the sameZATA PHARMACEUTICALS INC·Filed 2014·Granted Jan 8, 2019·1 cites·16 claims
- 0765US9617535B2Oligonucleotide complex compositions and methods of use as gene alteration toolsMASSACHUSETTS GEN HOSPITAL·Filed 2014·Granted Apr 11, 2017·0 cites·10 claims
- 0862US8084589B2Phosphoramidite nucleoside analogsBOGDANOV ALEXEI·Filed 2008·Granted Dec 27, 2011·1 cites·49 claims
- 0960US2021227827A1Method for pathogens, microorganisms, and parasites inactivationZATA PHARMACEUTICALS INC·Filed 2019·Application pending·0 cites
- 1060US2023204472A1Method for pathogens, microorganisms, and parasites inactivationNEW YORK BLOOD CENTER INC·Filed 2023·Application pending·0 cites
- 1158US11566042B2Phosphoramidite synthones for the synthesis of self-neutralizing oligonucleotide compoundsZATA PHARMACEUTICALS INC·Filed 2020·Granted Jan 31, 2023·0 cites·10 claims
- 1257US2010145321A1Methods and products for producing lattices of emr-treated islets in tissues, and uses thereforPALOMAR MEDICAL TECH INC·Filed 2009·Application pending·0 cites
- 1355US10738005B2Aziridinyl containing compounds and methods of inactivating nucleic acid molecules using the sameZATA PHARMACEUTICALS INC·Filed 2018·Granted Aug 11, 2020·0 cites·27 claims
- 1450US2012277659A1Sensor-lotion system for use with body treatment devicesYAROSLAVSKY ILYA·Filed 2012·Application pending·0 cites
- 1550US2010204310A1New modalities for treatment of drug-resistant tuberculosis and other diseasesZATA PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 1649US2006058712A1Methods and products for producing lattices of EMR-treated islets in tissues, and uses thereforPALOMAR MEDICAL TECH INC·Filed 2005·Application pending·0 cites
- 1749US2006004347A1Methods and products for producing lattices of EMR-treated islets in tissues, and uses thereforPALOMAR MEDICAL TECH INC·Filed 2005·Application pending·0 cites
- 1848US12297225B2Detection method for natural and modified small nucleic acidsZATA PHARMACEUTICALS INC·Filed 2019·Granted May 13, 2025·0 cites·9 claims
- 1947US2004137419A1Methods for removing microbicidal compounds from compositionsVI TECHNOLOGIES INC·Filed 2003·Application pending·0 cites
- 2046US2009069741A1Methods And Devices For Fractional Ablation Of Tissue For Substance DeliveryPALOMAR MEDICAL TECH INC·Filed 2008·Application pending·0 cites
- 2145US2006183676A1Treatment of mycobacterium tuberculosis with antisense oligonucleotidesHORWITZ MARCUS A·Filed 2002·Application pending·0 cites
- 2240US2011257584A1Methods and devices for injection of a substance into tissuePALOMAR MEDICAL TECH INC·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David R. Tabatadze files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →